Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2003

View Archived Issues

Sequential combination therapy reported effective in advanced follicular lymphoma

Motexafin lutetium phototherapy in coronary artery disease

Improved erectile dysfunction reported with moxonidine in hypertensive men

Antitumor efficacy and safety of arzoxifene in advanced endometrial cancer

Successful conversion of PSVT to sinus rhythm reported with tecadenoson

No adverse effects found with adalimumab on skin response to UVB irradiation

Sanofi-Synthelabo and Mitsubishi Pharma present new GSK-3beta inhibitors

New ICE/ced-3 inhibitors reported by Idun researchers

Basilea patent describes new ketolide antibiotics

Boehringer Ingelheim claims novel cytokine production inhibitors and their use

Novel glucocorticoid agonists developed by GSK researchers

Scientists at Pfizer discover new beta3-adrenoceptor agonists

New beta2-adrenoceptor agonists for use in respiratory disorders patented by GSK

SBIR grant for development of stem cell treatment for diabetic circulation ischemia

Orphan drug status for OGP(10-14)L for chronic idiopathic myelofibrosis

Acorda expands fampridine licensing rights

Resubmitted NDA for Helicide deemed not approvable

Biota signs influenza drug collaboration and license agreement with Sankyo

S.O.A.R. collaboration to evaluate KRX-101 for focal segmental glomerulosclerosis

Phase IIa trial confirms glucose-lowering ability of CS-917 in diabetics

NeuTec seeks development partners for Mycograb for cancer

Approvable letter issued for Enablex for overactive bladder

Savient and Teva in preliminary acquisition discussions

Favorable recommendation for Luveris in follicular development

CHF-4227: profile of a new SERM for osteoporosis

Optimer heading for clinical evaluation with new C. difficile-selective antibiotic

Bone anabolic effects of Apomine in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...